Works matching IS 00912700 AND DT 2022 AND VI 62 AND IP 8

Results: 13

A Time‐to‐Event Exposure‐Response Model for Amyloid‐Related Imaging Abnormalities Following Administration of Aducanumab to Subjects With Early Alzheimer Disease.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 8, p. 1030, doi. 10.1002/jcph.2047

By:

Muralidharan, Kumar Kandadi;
Karumanchi, Sravan;
Kowalski, Kenneth G.;
Burkett, Patrick;
Chapel, Sunny;
Rajagovindan, Raj;
Nestorov, Ivan

Publication type:

Article

Continued Risk of Dietary Supplements Adulterated With Approved and Unapproved Drugs: Assessment of the US Food and Drug Administration's Tainted Supplements Database 2007 Through 2021.

Published in:: Journal of Clinical Pharmacology, 2022, v. 62, n. 8, p. 928, doi. 10.1002/jcph.2046
Publication type:: Article

The Effect of Hepatic Impairment on the Pharmacokinetics of Intravenously Administered Felcisetrag (TAK‐954).

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 8, p. 1006, doi. 10.1002/jcph.2044

By:

Czerniak, Richard;
Cieslarová, Blanka;
Kupčová, Viera;
Rosario, Maria;
Lock, Ruth;
Dong, Cheng;
Dukes, George

Publication type:

Article

Drug Interactions With a Short Course of Nirmatrelvir and Ritonavir: Prescribers and Patients Beware.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 8, p. 925, doi. 10.1002/jcph.2060

By:

Ratain, Mark J.;
Greenblatt, David J.

Publication type:

Article

Hypertensive Crisis Following COVID‐19 Vaccination.

Published in:

2022

By:

Khani, Elnaz;
Entezari‐Maleki, Taher

Publication type:

Letter to the Editor

Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Impact of Chronic Kidney Disease on CYP3A4‐Mediated Metabolism of Saxagliptin.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 8, p. 1018, doi. 10.1002/jcph.2043

By:

Butrovich, Morgan A.;
Tang, Weifeng;
Boulton, David W.;
Nolin, Thomas D.;
Sharma, Pradeep

Publication type:

Article

Effect of Mild and Moderate Hepatic Impairment (Defined by Child–Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 8, p. 992, doi. 10.1002/jcph.2042

By:

Zahir, Hamim;
Greenberg, Jonathan;
Hsu, Ching;
Marbury, Thomas C.;
Lasseter, Kenneth C.;
Xu, Li‐An;
Tap, William D.;
Healey, John H.;
Stacchiotti, Silvia;
LaCreta, Frank

Publication type:

Article

Incidence of Antiseizure Medication–Induced Severe Cutaneous Adverse Reactions in Malaysia.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 8, p. 983, doi. 10.1002/jcph.2040

By:

Fong, Si‐Lei;
Lim, Kheng‐Seang;
Hariraj, Vidhya;
Lee, Sing‐Chet;
Wo, Wee‐Kee;
Ramli, Azuana;
Ho, Jun‐Hui;
Lai, Pauline Siew Mei;
Ng, Wei‐Leik

Publication type:

Article

Evaluation of the Efficacy of Dexmedetomidine as a Local Anesthetic Adjuvant in Children: A Meta‐Analysis of Randomized Controlled Trials.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 8, p. 935, doi. 10.1002/jcph.2039

By:

Sun, Yan;
Wu, Zhilin;
Sun, ShuJun;
Chen, Rui;
Dai, Maosha;
Dou, Xiaoke;
Lin, Yun

Publication type:

Article

Pediatric and Adult Placebo Response Rates in Placebo‐Controlled Clinical Trials Submitted to the US Food and Drug Administration 2012–2020.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 8, p. 970, doi. 10.1002/jcph.2035

By:

Park, Kyunghun;
Tran, Ngan K.;
Momper, Jeremiah D.;
Green, Dionna J.;
Burckart, Gilbert J.

Publication type:

Article

Physiologically Based Pharmacokinetic Modeling of Metformin in Children and Adolescents With Obesity.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 8, p. 960, doi. 10.1002/jcph.2034

By:

Ford, Jennifer Lynn;
Gerhart, Jacqueline G.;
Edginton, Andrea N.;
Yanovski, Jack A.;
Hon, Yuen Yi;
Gonzalez, Daniel

Publication type:

Article

Population Pharmacokinetic Analysis and Dosing Optimization of Sirolimus in Children With Tuberous Sclerosis Complex.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 8, p. 948, doi. 10.1002/jcph.2033

By:

Li, SiChan;
Zhan, Min;
Wu, SanLan;
Liao, JianXiang;
Xu, Hua;
Sun, Dan;
Zhao, Xia;
Wang, Yang

Publication type:

Article

Issue Information.

Published in:: Journal of Clinical Pharmacology, 2022, v. 62, n. 8, p. 919, doi. 10.1002/jcph.1664
Publication type:: Article